In vivo study of anti-inflammatory and antinociceptive activities of Copaifera pubiflora Benth oleoresin

Nat Prod Res. 2022 Feb;36(4):1129-1133. doi: 10.1080/14786419.2020.1855639. Epub 2020 Dec 8.

Abstract

Copaifera pubiflora Benth oleoresin (CPO) is used as an anti-inflammatory, wound healing, and antimicrobial. This paper reports the cytotoxic, anti-inflammatory, and antinociceptive activities of CPO. CPO (10 mg/kg) did not affect locomotor capacity in the open-field and rotarod tests and was not cytotoxic to CHO-k1, THP-1, and L929 cell lines. It was active in the formalin test at 3 mg/kg by 86 ± 3% and 96 ± 3%, respectively, for the first and second phases. At 10 mg/kg, CPO inhibited 90 ± 7%, the pain in the mechanical hyperalgesia test. In the tail-flick test, CPO at 3 mg/kg affected the tail-flick latencies in mice by 77 ± 20%, which in combination with naloxone was only partially reduced. At 3 mg/kg CPO inhibited 80 ± 12% the carrageenan-induced paw edema, and at 3 mg/kg it reduced by 91 ± 5% the nociception on acetic acid-induced abdominal writhing. Therefore, CPO possesses anti-inflammatory and antinociceptive activities.

Keywords: Copaiba oil; Copaifera oleoresin; Copaifera pubiflora; analgesic; anti-inflammatory.

MeSH terms

  • Analgesics* / pharmacology
  • Analgesics* / therapeutic use
  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Edema / chemically induced
  • Edema / drug therapy
  • Fabaceae*
  • Mice
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use

Substances

  • Analgesics
  • Anti-Inflammatory Agents
  • Plant Extracts
  • oleoresins